Dr. Revital Mandil-Levin

Advisory Board Member

Dr. Revital Mandil-Levin is a biotech executive with more than 15 years of experience in product and business development in the pharmaceutical industry, ranging from early stages startups to mature clinical stage pharmaceutical companies.

She has previously served as Chief Business Development Officer at CollPlant Holdings Ltd, and as Vice President Corporate Development at NeuroDerm Ltd (acquired by Mitsubishi Tanabe for $1.1 billion).

PhD in Biochemistry from Bar-Ilan University. MBA from the Israeli College of Management School of Business